Telomir Pharmaceuticals, Inc. Common Stock (TELO NASDAQ) stock market data APIs
$1.1502
0.02(1.7%)
as of July 3, 2025
Try our APIs with
free plan!
Telomir Pharmaceuticals, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on reversing biological aging and degenerative diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Progeria, Wilson's disease, and age-related macular degeneration (amd), as well as type 2 diabetes, cancer, and Alzheimer's disease. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.
Prev. Close
1.1502
Open
1.1697
High
1.2092
Low
1.1502
52 wk Range
1.15-8.4
Market Cap
34 227 K
Shares Outstanding
29 763 K
EPS
-0.07
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Telomir Pharmaceuticals, Inc. Common Stock data using free add-ons & libraries
Get Telomir Pharmaceuticals, Inc. Common Stock Fundamental Data
Telomir Pharmaceuticals, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Telomir Pharmaceuticals, Inc. Common Stock Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2025-05-14
- EPS/Forecast: -0.1
Get Telomir Pharmaceuticals, Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Telomir Pharmaceuticals, Inc. Common Stock News
New
TELO Rises on Promising Telomir-1 Preclinical Results
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) is among the 10 Best Growth Stocks Under $100 to Buy Now. On Wednesday, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) revealed that its leading product, Telom...
Telomir Pharmaceuticals To Present At BIO 2025, Eyes IND Filing For Telomir-1
(RTTNews) - Telomir Pharmaceuticals, Inc. (TELO), announced its participation in the BIO International Convention 2025, taking place June 16-19 in Boston, as the company advances toward submitting an ...
EXCLUSIVE: Telomir Pharma To Raise $3 Million Via Equity Financing To Fund Its Rare Disease IND
On Wednesday, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) announced that it had secured $3 million in equity financing through a direct investment by The Bayshore Trust, the company's largest sharehol...
Zacks Small Cap Research 2024 Initiations and Best Ideas for 2025
Zacks Small Cap Research was hard at work in 2024 initiating analyst coverage on 40 companies. Each of our initiation reports provides a valuation, investment thesis and financial forecast model that ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
